, Volume 193, Issue 6, pp 985–992 | Cite as

Lack of Association Between the IL1B (−511 and +3954), IL1RN VNTR Polymorphisms and Tuberculosis Risk: A Meta-analysis

  • Qiu-Pin Huang
  • Ning Liao
  • Hua Zhao
  • Min-Li Chen
  • Zheng-Fu XieEmail author



Several recent studies have provided evidence that polymorphisms in the interleukin-1 (IL1) gene are implicated in tuberculosis (TB). However, results of different studies are inconsistent. The aim of this study was to perform a meta-analysis investigating the association of the IL1B (−511 and +3954) and IL1RN VNTR polymorphisms with TB risk.


A systematic review of the English literature was conducted by searching Pubmed, Scopus, and ISI Web of Knowledge databases for relevant studies. Pooled odds ratios (OR) with 95 % confidence intervals (CI) were calculated using fixed effects models. Between-study heterogeneity and publication bias were also evaluated.


Nine case–control studies including 3327 participants were reviewed and analyzed. Our results did not indicate any association of the IL1B (−511 and +3954) and IL1RN VNTR polymorphisms with TB risk in the overall populations. The pooled OR of the IL1B −511 polymorphism was 1.09 (95 % CI 0.87–1.36) for the dominant model, 1.11 (0.89–1.38) for the recessive model, 1.15 (0.87–1.50) for the homozygote model, and 1.07 (0.94–1.23) for the allelic comparison model. ORs for the IL1B +3954 and IL1RN VNTR polymorphisms were similar. In subgroup analysis stratified by ethnicity, the results revealed no association between these polymorphisms and TB risk in black people, Asians, and Caucasians, respectively. We did not identify significant between-study heterogeneity across all studies, and there was no evidence of publication bias.


Our results indicate there is a lack of association between the IL1B (−511 and +3954), IL1RN VNTR polymorphisms and TB risk.


Interleukin-1 Meta-analysis Polymorphism Tuberculosis 



We would like to thank Dr. Jian Huang for his valuable suggestions and editing support.

Compliance with Ethical Standards

Conflicts of interest



  1. 1.
    Silva DR, Menegotto DM, Schulz LF et al (2010) Factors associated with mortality in hospitalized patients with newly diagnosed tuberculosis. Lung 188:33–41CrossRefPubMedGoogle Scholar
  2. 2.
    Knechel NA (2009) Tuberculosis: pathophysiology, clinical features, and diagnosis. Crit Care Nurse 29:34–43CrossRefPubMedGoogle Scholar
  3. 3.
    Abel L, El-Baghdadi J, Bousfiha AA et al (2014) Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B 369:20130428CrossRefGoogle Scholar
  4. 4.
    Tong X, Chen L, Liu S et al (2015) Polymorphisms in HLA-DRB1 gene and the risk of tuberculosis: a meta-analysis of 31 studies. Lung 193:309–318CrossRefPubMedGoogle Scholar
  5. 5.
    Moravej A, Rasouli M, Kalani M et al (2012) IL-1β (-511T/C) gene polymorphism not IL-1β (+3953T/C) and LT-α(+252A/G) gene variants confers susceptibility to visceral leishmaniasis. Mol Biol Rep 39:6907–6914CrossRefPubMedGoogle Scholar
  6. 6.
    Mühlberg T, Kirchberger M, Spitzweg C et al (1998) Lack of association of Graves’ disease with the A2 allele of the interleukin-1 receptor antagonist gene in a white European population. Eur J Endocrinol 138:686–690CrossRefPubMedGoogle Scholar
  7. 7.
    Bellamy R, Ruwende C, Corrah T et al (1998) Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tuber Lung Dis 79:83–89CrossRefPubMedGoogle Scholar
  8. 8.
    Wilkinson RJ, Patel P, Llewelyn M et al (1999) Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 189:1863–1874PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Delgado JC, Baena A, Thim S et al (2002) Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 186:1463–1468CrossRefPubMedGoogle Scholar
  10. 10.
    Awomoyi AA, Charurat M, Marchant A et al (2005) Polymorphism in IL1B-ILIB-511 association with tuberculosis and decreased lipopolysaccharide-induced IL-1 beta in IFN-gamma primed ex vivo whole blood assay. J Endotoxin Res 11:281–286PubMedGoogle Scholar
  11. 11.
    Amirzargar AA, Rezaei N, Jabbari H et al (2006) Cytokine single nucleotide polymorphisms in Iranian patients with pulmonary tuberculosis. Eur Cytokine Netw 17:84–89PubMedGoogle Scholar
  12. 12.
    Sun H, Wang Y, Ma X et al (2007) A method of oligochip for single nucleotide polymorphism genotyping in the promoter region of the interleukin-1 beta gene and its clinical application. Oligonucleotides 17:336–344CrossRefPubMedGoogle Scholar
  13. 13.
    Naslednikova IO, Urazova OI, Voronkova OV et al (2009) Allelic polymorphism of cytokine genes during pulmonary tuberculosis. Bull Exp Biol Med 148:175–180CrossRefPubMedGoogle Scholar
  14. 14.
    Meenakshi P, Ramya S, Shruthi T et al (2013) Association of IL-1β +3954 C/T and IL-10 -1082 G/A cytokine gene polymorphisms with susceptibility to tuberculosis. Scand J Immunol 78:92–97CrossRefPubMedGoogle Scholar
  15. 15.
    Hashemi M, Naderi M, Ebrahimi M et al (2015) Association between interleukin-1 receptor antagonist (IL1RN) variable number of tandem repeats (VNTR) polymorphism and pulmonary tuberculosis. Iran J Allergy Asthma Immunol 14:55–59PubMedGoogle Scholar
  16. 16.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748PubMedGoogle Scholar
  17. 17.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMedGoogle Scholar
  18. 18.
    Kienast K, Knorst M, Müller-Quernheim J et al (1996) Modulation of IL-1 beta, IL-6, IL-8, TNF-alpha, and TGF-beta secretions by alveolar macrophages under NO2 exposure. Lung 174:57–67PubMedGoogle Scholar
  19. 19.
    Dinarello CA (2005) Interleukin-1beta. Crit Care Med 33:S460–S462CrossRefPubMedGoogle Scholar
  20. 20.
    Wang CH, Kuo HP (2001) Nitric oxide modulates interleukin-1beta and tumour necrosis factor-alpha synthesis, and disease regression by alveolar macrophages in pulmonary tuberculosis. Respirology 6:79–84CrossRefPubMedGoogle Scholar
  21. 21.
    Tsao TC, Li L, Hsieh M et al (1999) Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in activepulmonary TB. Eur Respir J 14:490–495CrossRefPubMedGoogle Scholar
  22. 22.
    Tsao TC, Hong Jh, Li LF et al (2000) Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest 117:103–109CrossRefPubMedGoogle Scholar
  23. 23.
    Juffermans NP, Verbon A, van Deventer SJ et al (1998) Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 157:1328–1331CrossRefPubMedGoogle Scholar
  24. 24.
    Akalin H, Akdiş AC, Mistik R et al (1994) Cerebrospinal fluid interleukin-1 beta/interleukin-1 receptor antagonist balance and tumor necrosis factor-alpha concentrations in tuberculous, viral and acute bacterial meningitis. Scand J Infect Dis 26:667–674CrossRefPubMedGoogle Scholar
  25. 25.
    Danis VA, Millington M, Hyland VJ et al (1995) Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99:303–310PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Naing C, Mak JW, Maung M et al (2013) Meta-analysis: the association between HIV infection and extrapulmonarytuberculosis. Lung 191:27–34CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Qiu-Pin Huang
    • 1
  • Ning Liao
    • 1
  • Hua Zhao
    • 1
  • Min-Li Chen
    • 1
  • Zheng-Fu Xie
    • 1
    Email author
  1. 1.Department of Geriatrics and Gerontology, First Affiliated HospitalGuangxi Medical UniversityNanningChina

Personalised recommendations